The funding supports the SANGREAL Project in collaboration with Advanced Electric Machines.
"The automotive industry is at a pivotal point. Great ideas will not move the dial on decarbonisation unless they are on the road and taking the place of more polluting technology. The future movement of people and goods needs to be efficient and green. There has been real progress in the decarbonisation of cars to meet the UK Government’s plans to phase-out sales of new petrol and diesel cars and vans from 2030. However, the pathways for Medium and Heavy duty and long-range transport are less clear."
— Jon Beasley, Business Development and Programmes Director
The grant from WRAP will be used to introduce new features to the Kitche app and platform.
"We’re pleased that the UK government is taking home food waste seriously and proud to be selected among only a handful of companies to work with DEFRA and WRAP. Using a data-driven approach and a host of unique app functionality, we aim to help citizens Eat What They Buy and Buy What They Eat."
The company received support in the latest round of the Artificial Intelligence in Health and Care Award.
"The Navenio team is both honoured and delighted to receive the AI in Health and Care Award. The funding will help us accelerate being able to support more teams and patients across the NHS, as we look to build on the positive impact that our technology has provided, particularly during the pandemic. Artificial intelligence is one of many technologies making a real world impact in the healthcare sector, and Navenio is proud to help spearhead digital transformation alongside the other award recipients"
The grant will support the development of the CUOREMA project with international collaborators.
"We are thrilled to be partnering with such talented and diverse teams on this innovative and important project over the next few years. Each organisation brings a very unique perspective to the table, allowing for a thoughtful and comprehensive approach to tackling heart health. I am extremely passionate about digital health and this has the potential to change many lives for the better, helping us transform cardiac rehabilitation for patients across Europe."
The company has received funding from Innovate UK to apply its artificial intelligence platform to glioblastoma multiforme research.
"The goal of GlamAI is to break new ground in applications of AI for drug discovery and accelerate the path to personalized medicine in labs around the world. We are very proud of the progress we’ve made so far to validate our approach. Through our partnership with King’s College London, GlamAI will collaborate with experts in glioblastoma multiforme and will secure access to disease cell-lines that best represent the tumor in patients. The funding received from Innovate UK is key to progress this highly innovative project and to accelerate the path to treatment for this deadly disease."
